Healthcare Professional (HCP) Survey to Assess the Effectiveness of the Additional Risk Minimization Measures (aRMM) for Casgevy® (exagamglogene autotemcel)

08/08/2025
03/09/2026
EU PAS number:
EUPAS1000000704
Study
Ongoing

ENCePP Code of conduct

No information provided.
Data sources

Data source(s), other

The data source will be surveys completed by HCPs who have counseled patients regarding Casgevy as a treatment option at ATCs.

Data sources (types)

Other

Data sources (types), other

Health Care Provider survey
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

Unknown
Procedures
No information provided.